Table 3.
|
PHQ class 1 (“stable high”; n=10) | PHQ class 2 (“improving high”; n=17) | PHQ class 3 (“improving moderate”; n=77) | PHQ class 4 (“stable moderate”; n=56) | PHQ class 5 (“improving low”; n=61) | |
Participants (n=221), n (%) | 10 (4.52) | 17 (7.69) | 77 (34.84) | 56 (25.34) | 61 (27.6) | |
Age (years), mean (SD) | 30.1 (13.92) | 34.47 (13.31) | 31.31 (11.43) | 32.38 (13.48) | 35.41 (13.01) | |
Baseline PHQ-9 score, mean (SD) | 21.6 (2.95) | 21.41 (2.58) | 14.12 (3.52) | 16.05 (2.94) | 8 (3.61) | |
Week 12 PHQ-9 score, mean (SD) | 21.4 (2.07) | 7.88 (3.64) | 6.64 (3.89) | 13.64 (3.55) | 3.64 (2.10) | |
Baseline GAD-7a score, mean (SD) | 17.4 (3.47) | 16.65 (3.00) | 11.96 (5.03) | 13.55 (4.32) | 9.39 (4.14) | |
Week 12 GAD-7 score, mean (SD) | 14.2 (5.31) | 5.75 (3.11) | 5.56 (3.80) | 11.42 (4.46) | 3.72 (3.58) | |
Sex (male), n (%) | 1 (10) | 6 (35) | 25 (32) | 16 (29) | 15 (25) | |
Employment status (employed full time), n (%) | 6 (60) | 14 (82) | 60 (78) | 36 (64) | 50 (82) | |
Psychiatric medication status (prescribed and taking), n (%) | 7 (70) | 12 (71) | 29 (38) | 25 (45) | 14 (23) | |
Long-term condition (no), n (%) | 8 (80) | 12 (71) | 61 (79) | 45 (80) | 50 (82) | |
Program type, n (%) | ||||||
|
Comorbid | 6 (60) | 10 (59) | 35 (45) | 32 (57) | 21 (34) |
|
Depression | 1 (10) | 6 (35) | 21 (27) | 14 (25) | 8 (13) |
|
Anxiety | 3 (30) | 1 (6) | 21 (27) | 10 (18) | 32 (52) |
aGAD-7: Generalized Anxiety Disorder-7.